Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06068400Not ApplicableTerminated
Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
PrincipalinvestigatorStart date: 2023-09-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Shenzhen Nanshan District Shekou People's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Gang An

Institute of Hematology & Blood Diseases Hospital Ethics Committee

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Marc S. Raab, PD Dr. med.

Medizinische Klinik V, University Hospital Heidelberg

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Jin Lu, PhD

Peking University People's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Sven Gogov, MD

Incyte Corporation

Moderately Similar
3 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Ravi Vij, M.D.

Washington Universtiy in St. Louis

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Martin Kaiser

Institute of Cancer Research, United Kingdom

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Jianmin luo, PhD&MD

The Second Hospital of Hebei Medical University

Moderately Similar
4 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Amitabha Mazumder, MD

NYU Langone Health

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Lugui Qiu

Chinese Academy of Medical Sciences & Peking Union Medical College

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Qing Zhang, Doctoral

Guangdong Second Provincial General Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06068400Not ApplicablePrincipalInvestigator

Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma
Terminated

All 1 trials loaded